Concepedia

Publication | Open Access

The prognostic role of 1q21 gain/amplification in newly diagnosed multiple myeloma: The faster, the worse

28

Citations

32

References

2023

Year

Abstract

In the setting of novel therapy, 1q gain/amp still acts as an independent adverse prognostic factor. Patients with 1q gain/amp achieved VGPR rapidly but had inferior survival.

References

YearCitations

Page 1